Cargando…

Drug promotional literature distributed by pharmaceutical companies: Do they provide enough information to ascertain their validity?

Detalles Bibliográficos
Autores principales:	Jaykaran, Saxena, Deepak, Yadav, Preeti, Kantharia, N. D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications Pvt Ltd 2011
Materias:	Research Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157133/ https://www.ncbi.nlm.nih.gov/pubmed/21897717 http://dx.doi.org/10.4103/0976-500X.83288

Ejemplares similares

Gender and racial bias in drug promotional material distributed by pharmaceutical companies
por: Jaykaran,, et al.
Publicado: (2012)

Nonsignificant P values cannot prove null hypothesis: Absence of evidence is not evidence of absence
por: Jaykaran,, et al.
Publicado: (2011)

Drug advertisements published in Indian Medical Journals: Are they ethical?
por: Charan, Jaykaran, et al.
Publicado: (2011)

Quality of Antidepressant Drugs Research Articles Published in Indian Medical Journals
por: Charan, Jaykaran, et al.
Publicado: (2011)

Clinical trials registered in clinical trial registry of India: A survey
por: Yadav, Preeti, et al.
Publicado: (2011)

Reporting of method of animal sacrifice in articles published in Indian journals
por: Jaykaran,, et al.
Publicado: (2011)

Doctors’ opinions of information provided by Libyan pharmaceutical company representatives
por: Alssageer, Mustafa A., et al.
Publicado: (2012)

Negative animal studies published in Indian Medical Journal: Are they methodologically strong enough to conclude what they are concluding?
por: Charan, Jaykaran, et al.
Publicado: (2014)

Factors associated with performance of second year student in pharmacology examinations
por: Jaykaran,, et al.
Publicado: (2011)

Intern doctors’ feedback on teaching methodologies in pharmacology
por: Jaykaran,, et al.
Publicado: (2010)

Effect of Fluoxetine on Some Cognitive Functions of Patients of Depression
por: Jaykaran,, et al.
Publicado: (2009)

Antibiotics for the Treatment of Leptospirosis: Systematic Review and Meta-Analysis of Controlled Trials
por: Charan, Jaykaran, et al.
Publicado: (2013)

Vitamin D for prevention of respiratory tract infections: A systematic review and meta-analysis
por: Charan, Jaykaran, et al.
Publicado: (2012)

Buyouts of Indian Pharmaceutical Companies by Multinational Pharmaceutical Companies: An Issue of Concern
por: Sreedhar, D, et al.
Publicado: (2011)

Do companies in the pharmaceutical supply chain earn excess returns?
por: Sood, Neeraj, et al.
Publicado: (2021)

Informed consent: Are we doing enough?
por: Pranati,
Publicado: (2010)

The influence of pharmaceutical companies
por: Migone, Paolo
Publicado: (2017)

Pharmaceutical companies and healthcare providers: Going beyond the gift – An explorative review
por: Latten, Tom, et al.
Publicado: (2018)

Patient Satisfaction With Providers: Do Patient Surveys Give Enough Information to Help Providers Improve Specific Behaviors
por: North, Frederick, et al.
Publicado: (2019)

Pharmacovigilance in pharmaceutical companies: An overview
por: Mammì, Maria, et al.
Publicado: (2013)

How to calculate sample size in animal studies?
por: Charan, Jaykaran, et al.
Publicado: (2013)

Pharmacovigilance obligations of the pharmaceutical companies in India
por: Arora, Deepa
Publicado: (2008)

Involvement of pharmaceutical companies at scientific meetings
por: Brink, Andries
Publicado: (2010)

Regulating pharmaceutical companies’ financial largesse
por: Avraham, Ronen, et al.
Publicado: (2018)

The Pharmaceutical Company Approach to Antibiotic Policies
por: White, Anthony R.
Publicado: (2005)

Ethics, gastroenterologists, and pharmaceutical and equipment companies
por: Roberts‐Thomson, Ian C
Publicado: (2020)

Expected Impact of Biosimilars on the Pharmaceutical Companies
por: Golshani, Shiva, et al.
Publicado: (2021)

Effects of fluoxetine and escitalopram on C-reactive protein in patients of depression
por: Chavda, Nilesh, et al.
Publicado: (2011)

Medical Affairs in Pharmaceutical Companies and Related Pharmaceutical Regulations in Japan
por: Maeda, Hideki
Publicado: (2021)

Quality of reporting statistics in two Indian pharmacology journals
por: Jaykaran,, et al.
Publicado: (2011)

Pharmaceutical Company Targets and Strategies to Address Climate Change: Content Analysis of Public Reports from 20 Pharmaceutical Companies
por: Booth, Amy, et al.
Publicado: (2023)

ICCVAM: Not Doing Enough
por: Sandler, Jessica
Publicado: (2010)

Error in Payments From Some Pharmaceutical Companies
Publicado: (2019)

Unmet Medical Needs and the Role of Pharmaceutical Companies
por: Meyer-Sabellek, Wolfgang
Publicado: (2009)

New Delhi Metallo – beta lactamase – 1 containing Enterobacteriaceae: Origin, Diagnosis, Treatment and Public health concern
por: Charan, Jaykaran, et al.
Publicado: (2012)

Effect of antihypertensive therapy on cognitive functions of patients with hypertension
por: Jaiswal, Ashok, et al.
Publicado: (2010)

Information from Pharmaceutical Companies and the Quality, Quantity, and Cost of Physicians' Prescribing: A Systematic Review
por: Spurling, Geoffrey K., et al.
Publicado: (2010)

What do Libyan doctors perceive as the benefits, ethical issues and influences of their interactions with pharmaceutical company representatives?
por: Alssageer, Mustafa Ali, et al.
Publicado: (2013)

Validity of tools used for surveying physicians about their interactions with pharmaceutical company: a systematic review
por: Lotfi, Tamara, et al.
Publicado: (2015)

Matched Ascertainment of Informative Families for Complex Genetic Modelling
por: Yip, Benjamin H., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_9fj4dlmij9vhgmluk2nl3k2l1p